glp-1 receptor agonist bcbs Understanding agonists and their impact on drug discovery GLP-1 receptor agonists for individualized
Description
Gain a more in-depth understanding of past, current and future GLP-1 users
The GLP-1 Receptor Agonist market size is expected to reach $18.32 billion in 2030 at a CAGR of 5.4%, driven by rising prevalence of diabetes.
Moreover, the addition of finerenone to this combination therapy could potentially provide stronger cardiorenal protective benefits
If you are among them, one...
